CFP Survey Announcment Box

Article

TALK NERDY TO US TAKE OUR TECH SURVEY FOR A CHANCE AT $500! What are physicians saying, thinking - and doing - when it comes to implementing office technologies? Help us to help you find out by completing our easy survey. We are working with our sister site, PhysiciansPractice.com, to learn all about it -- and we're willing to pay. Just go to the 2012 Tech Survey to complete our easy survey, and enter to win a $500 Visa gift card. It only takes five minutes. The contest will run through February 29th. No purchase is necessary. Void where prohibited. See official rules for full details, available here. Thank you for your participation!

TALK NERDY TO US

TAKE OUR TECH SURVEY FOR A CHANCE AT $500!

What are physicians saying, thinking - and doing - when it comes to implementing office technologies? Help us to help you find out by completing our easy survey.

We are working with our sister site, PhysiciansPractice.com, to learn all about it -- and we're willing to pay. Just go to the 2012 Tech Survey to complete our easy survey, and enter to win a $500 Visa gift card. It only takes five minutes.

The contest will run through February 29th. No purchase is necessary. Void where prohibited. See official rules for full details, available here.

Thank you for your participation!

Recent Videos
3 KOLs are featured in this series.
3 KOLs are featured in this series.
3 KOLs are featured in this series.
Linda DiMeglio, MD, MPH
Alan Percy, MD
Alan Percy, MD
3 KOLs are featured in this series.
3 KOLs are featured in this series.
Related Content
Marinus discontinuing oral ganaxolone trial development for treatment of seizures in children | Image Credit: © SewcreamStudio - © SewcreamStudio - stock.adobe.com.

Marinus discontinuing oral ganaxolone trial development to treat seizures in children

Joshua Fitch, Senior Editor
October 24th 2024
Article

The TrustTSC trial did not achieve its primary endpoint of percent reduction in 28-day frequency of TSC-associated seizures.

Site Logo

Food Insecurity and the Dangers of Infant Formula Dilution

January 30th 2023
Podcast
Pneumococcal conjugate vaccine: A glimpse into current recommendationsLatest revision | Image Credit: © AdobeStock_74430853 - © AdobeStock_74430853 - stock.adobe.com.

Pneumococcal conjugate vaccine: A glimpse into current recommendations

Ann McArn, PharmD;Carlton Lee, PharmD, MPH, FASHP, FPPAG, BCPPS
October 24th 2024
Article

Infants, young children, and older adults are at the highest risk for pneumococcal infection, and viral illnesses, such as influenza, may predispose sensitive groups to pneumococcal infection.

Demystifying Infant Formula

Demystifying Infant Formula

October 11th 2022
Podcast
Galinpepimut-S to treat pediatric acute myeloid leukemia receives Rare Disease Designation | Image Credit: © John Doe - © John Doe - stock.adobe.com.

Galinpepimut-S to treat pediatric acute myeloid leukemia receives Rare Disease Designation

Joshua Fitch, Senior Editor
October 23rd 2024
Article

Interim analysis of the phase 3 REGAL Trial is anticipated in this quarter of 2024.

Maternal influenza linked to offspring seizure risk | Image Credit: © sebra - © sebra - stock.adobe.com.

Maternal influenza linked to offspring seizure risk

Celeste Krewson, Assistant Editor
October 23rd 2024
Article

In a recent study, infants of mothers with an influenza infection during pregnancy were significantly more likely to experience febrile seizures, but not epilepsy.

© 2024 MJH Life Sciences

All rights reserved.